Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptoms

Alzheimer s & Dementia(2025)10.1002/alz.70831Source: DataRank Database

Tau mediates the impact of amyloid and vascular disease burden on the trajectory of clinical symptoms is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.80)OA: hybridTopics (50)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Rebecca L. Koscik ORCID,Bruce P. Hermann ORCID,Erin M. Jonaitis ORCID,Tobey J. Betthauser ORCID,Leonardo A. Rivera‐Rivera ORCID

Live enrichment

PubMed:41164853 PMC:PMC12572831 OpenAlex:https://openalex.org/W4415690740

National Institutes of Health

Grant: R01AG021155

National Institutes of Health

Grant: R01 AG027161

National Institutes of Health

Grant: P30AG062715

National Institutes of Health

Grant: S10OD025245‐01

National Institutes of Health

Grant: R01AG080766

National Institutes of Health

Grant: R21AG077337

National Institutes of Health

Grant: R01AG089562

National Institutes of Health

Grant: R01AG075788

National Institutes of Health

Grant: R01AG082208

Alzheimer's Association

Grant: AARF‐19‐614533

NIH HHS

Grant: S10 OD025245

NIH HHS

Grant: S10OD025245-01

Alzheimer's Association

Grant: AARF-19-614533

FWCI

0.80

Citation Percentile

0.8%

Citation Trend

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1002/alz.70831

publisherhttps://doi.org/10.1002/alz.70831

publisherhttps://alz-journals.onlinelibrary.wiley.com/doi/pdf/10.1002/alz.70831

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41164853

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12572831

Fields of Study

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsFunctional Brain Connectivity StudiesHumansMaleFemaletau ProteinsAgedPositron-Emission TomographyMagnetic Resonance ImagingCognitive DysfunctionDisease ProgressionWhite MatterLongitudinal StudiesBiomarkersVascular DiseasesMental Status and Dementia TestsAged, 80 and overAmyloidAmyloid beta-Peptides

MeSH Terms

Mental Status and Dementia TestsAgedAged, 80 and overAmyloidFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleVascular DiseasesBiomarkersAmyloid beta-Peptidestau ProteinsDisease ProgressionPositron-Emission TomographyCognitive DysfunctionWhite Matter

Keywords

CognitionCognitive declineDiseaseHyperintensityDementiaAmyloid βAmyloid (mycology)Tau pathologyVascular dementiaAmyloidClinical Dementia RatingWhite Matter HyperintensitiesPreclinical Alzheimer's Disease